Clinical Trials Directory

Trials / Unknown

UnknownNCT01778725

Early Identification of Brain Insult in Chorioamnionitis

S100B as a Marker for Fetal Brain Injury in Premature Rupture of Membranes

Status
Unknown
Phase
Study type
Observational
Enrollment
90 (estimated)
Sponsor
Sheba Medical Center · Other Government
Sex
Female
Age
18 Years – 55 Years
Healthy volunteers
Accepted

Summary

Premature breaking of the amniotic fluids during pregnancy caries high risk for infection of the amniotic fluid. One of the results of chorioamnionitis is brain injury of the fetus. Fetus' brain is highly vulnerable and could be harmed even by mild inflammation before fulminant infection is developed. The aim of this study is to identify, as early as, possible signs of brain injury. S100B protein will be used as a marker for brain insult. S100b level were associated with the occurrence and size of stroke and brain trauma in adults and children. Moreover, S100B crosses the membrane and its level in women with preterm labor was associated with brain injury of preterm infant. The study question is whether the levels of S100B in women with early amniotic fluids breakdown are associated with future brain injury of the infant, as assessed by head ultrasound and neurological examination.

Conditions

Timeline

Start date
2013-01-01
Primary completion
2015-08-01
First posted
2013-01-29
Last updated
2013-01-29

Locations

1 site across 1 country: Israel

Source: ClinicalTrials.gov record NCT01778725. Inclusion in this directory is not an endorsement.

Early Identification of Brain Insult in Chorioamnionitis (NCT01778725) · Clinical Trials Directory